Funded Tech Companies

Vedere Bio II

Vedere Bio II is a biopharmaceutical venture, based in Cambridge. Financial backing came from Octagon Investments Fund, Atlas Venture and Mission BioCapital.

Company Overview

Company Name
Vedere Bio II
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
300 Technology Sq. 8th Floor
Cambridge, MA 02139
USA

Company Background Information

Overview
Vedere Bio II is pioneering beyond traditional gene therapy to not just slow vision loss from inherited retinal degenerations (IRDs) or dry age-related macular degeneration (dry AMD) with geographic atrophy (GA), but actually restore it.
Profile
Vedere Bio II LinkedIn Company Profile
Social Media
Vedere Bio II Company Twitter Account
Company News
Vedere Bio II News
Facebook
Vedere Bio II on Facebook
YouTube
Vedere Bio II on YouTube
Last Transaction
5/19/2021

Financing History

Date
Type
Amount
Venture Equity
$77,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Cyrus Mozayeni
  Cyrus Mozayeni LinkedIn Profile  Cyrus Mozayeni Twitter Account  Cyrus Mozayeni News  Cyrus Mozayeni on Facebook
Chief Operating Officer
Mark Gaffney
  Mark Gaffney LinkedIn Profile  Mark Gaffney Twitter Account  Mark Gaffney News  Mark Gaffney on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Vedantra Pharmaceuticals | Vedero Software

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary